Reply: How Do the New Definitions for Multidrug-Resistant Tuberculosis Treatment Outcomes Really Perform?

Am J Respir Crit Care Med. 2015 Jul 1;192(1):117-8. doi: 10.1164/rccm.201504-0747LE.

Affiliations

¹ 1 Epicentre Paris, France.
² 2 Médecins Sans Frontières London, United Kingdom.
³ 3 Tashkent Pediatric Medical Institute Tashkent, Uzbekistan.
⁴ 4 National Tuberculosis Control Office Yerevan, Armenia.
⁵ 5 Programmatic Management of Drug-Resistant Tuberculosis Nairobi, Kenya.
⁶ 6 National Tuberculosis Program Sukhumi, Abkhazia.
⁷ 7 Ministry of Health-TB National Control Program Mbanane, Swaziland.
⁸ 8 Médecins Sans Frontières Geneva, Switzerland.
⁹ 9 Médecins Sans Frontières Paris, France.

PMID: 26131996
DOI: 10.1164/rccm.201504-0747LE

No abstract available

Publication types

Letter
Comment

MeSH terms

Antitubercular Agents / therapeutic use*
Female
Humans
Male
Microbial Sensitivity Tests*
Mycobacterium tuberculosis / drug effects*
Tuberculosis, Multidrug-Resistant / drug therapy*

Substances

Antitubercular Agents